Showing results (871-880 of 1,038) with videos related to

Sort By:
Pageof 104
Genetic Counseling (Geneva, Switzerland)|January 1, 1997
Penetrance of familial hypertrophic cardiomyopathyP Charron, L Carrier, O Dubourg, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2010
A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridolMark A Dickson, Manish A Shah, Dana Rathkopf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2011
Imaging colon cancer response following treatment with AZD1152: a preclinical analysis of [18F]fluoro-2-deoxyglucose and 3'-deoxy-3'-[18F]fluorothymidine imagingMaxim A Moroz, Tatiana Kochetkov, Shangde Cai, et al.
Gastrointestinal Cancer Research : GCR|January 8, 2013
A Nonrandomized, Phase II Study of Sequential Irinotecan and Flavopiridol in Patients With Advanced Hepatocellular CarcinomaCelina Ang, Eileen M O'Reilly, Richard D Carvajal, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|June 11, 2026
Spinal cord FDG PET uptake in healthy adults: an AI-driven segmentation studyRithvik Kata, Darshil Patel, Om H Gandhi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcomaM A Dickson, M R Mahoney, W D Tap, et al.
NMR in Biomedicine|October 14, 2011
Preclinical study of treatment response in HCT-116 cells and xenografts with (1) H-decoupled (31) P MRSMoses M Darpolor, Peter T Kennealey, H Carl Le, et al.
Immunogenetics|May 10, 2000
Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group BW Wiszniewski, M C Fondaneche, N Lambert, et al.
Clinical Nuclear Medicine|February 29, 2020
FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With PembrolizumabRandy Yeh, Megan H Trager, Emanuelle M Rizk, et al.
Joint Commission Journal on Quality and Patient Safety|June 13, 2014
Using a triggered endocrinology service consultation to improve the evaluation, management, and follow-up of osteoporosis in hip-fracture patientsHeather L Hofflich, Deborah K Oh, Charles H Choe, et al.
Pageof 104